MAPT and Alzheimer disease: The diagnosis of AD is based on the cognitive, functional, and behavioral scores of the patient, medical evaluation by doctors, combined with PET or MRI brain imaging, and analysis of biomarkers such as Aβ42/40, p-tau, glia fibrillary acid protein, and neurofilament light from CSF (cerebrospinal fluid) or blood.